Exciting News: MoU Signed between Vins Bioproducts, India, and Atlantic Lifesciences, Ghana! 🤝 The Receipt of Ready-to-Fill Anti-Snake Venom Serum Bulk 📷 #Biotech#Collaboration
Exciting News: MoU Signed between Vins Bioproducts, India, and Atlantic Lifesciences, Ghana! 🤝 The Receipt of Ready-to-Fill Anti-Snake Venom Serum Bulk 📷 #Biotech#Collaboration
@VINS Bioproducts, in partnership with @ccmb_csir and Univ of Hyderabad, announced completion of phase-2 trials of VINCOV-19, India’s first antidote against COVID 19. VINCOV-19 is ready for market authorisation.
https://t.co/7jTuBaMEIw
#CovidIsNotOver#Hyderabad
VINCOV-19, first COVID antidote, completes phase 2 clinical trials
VINS Bioproducts Limited, in collaboration with the CCMB and UoH, announced the successful completion of phase 2 clinical trials of VINCOV-19
https://t.co/Kb83SvEl0B
Our presence at 22nd Annual Conference on Rabies APCRI (Association for Prevention and Control of Rabies in India), on 17th & 18th September, 2022 in Kolkata.